Literature DB >> 17047093

Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study.

C Vollmert, O Windl, W Xiang, A Rosenberger, I Zerr, H-E Wichmann, H Bickeböller, T Illig, H A Kretzschmar.   

Abstract

BACKGROUND: A single nucleotide polymorphism (SNP) in the coding region of the prion protein gene (PRNP) at codon 129 has been repeatedly shown to be an associated factor to sporadic Creutzfeldt-Jakob disease (sCJD), but additional major predisposing DNA variants for sCJD are still unknown. Several previous studies focused on the characterisation of polymorphisms in PRNP and the prion-like doppel gene (PRND), generating contradictory results on relatively small sample sets. Thus, extensive studies are required for validation of the polymorphisms in PRNP and PRND.
METHODS: We evaluated a set of nine SNPs of PRNP and one SNP of PRND in 593 German sCJD patients and 748 German healthy controls. Genotyping was performed using MALDI-TOF mass spectrometry.
RESULTS: In addition to PRNP 129, we detected a significant association between sCJD and allele frequencies of six further PRNP SNPs. No significant association of PRND T174M with sCJD was shown. We observed strong linkage disequilibrium within eight adjacent PRNP SNPs, including PRNP 129. However, the association of sCJD with PRNP 1368 and PRNP 34296 appeared to be independent on the genotype of PRNP 129. We additionally identified the most common haplotypes of PRNP to be over-represented or under-represented in our cohort of patients with sCJD.
CONCLUSION: Our study evaluated previous findings of the association of SNPs in the PRNP and PRND genes in the largest cohorts for association study in sCJD to date, and extends previous findings by defining for the first time the haplotypes associated with sCJD in a large population of the German CJD surveillance study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047093      PMCID: PMC2563174          DOI: 10.1136/jmg.2006.040931

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  29 in total

1.  Isolation and functional characterisation of the promoter region of the human prion protein gene.

Authors:  S P Mahal; E A Asante; M Antoniou; J Collinge
Journal:  Gene       Date:  2001-05-02       Impact factor: 3.688

2.  Identification of multiple quantitative trait loci linked to prion disease incubation period in mice.

Authors:  S E Lloyd; O N Onwuazor; J A Beck; G Mallinson; M Farrall; P Targonski; J Collinge; E M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

3.  First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases.

Authors:  K Peoc'h; C Guérin; J P Brandel; J M Launay; J L Laplanche
Journal:  Neurosci Lett       Date:  2000-06-02       Impact factor: 3.046

4.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Pocchiari; S Collins; J P Brandel; J de Pedro Cuesta; R S Knight; H Bernheimer; F Cardone; N Delasnerie-Lauprêtre; N Cuadrado Corrales; A Ladogana; M Bodemer; A Fletcher; T Awan; A Ruiz Bremón; H Budka; J L Laplanche; R G Will; S Poser
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

5.  Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice.

Authors:  K Manolakou; J Beaton; I McConnell; C Farquar; J Manson; N D Hastie; M Bruce; I J Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

6.  Polymorphisms at codons 56 and 174 of the prion-like protein gene (PRND) are not associated with sporadic Creutzfeldt-Jakob disease.

Authors:  Byung-Hoon Jeong; Nam-Ho Kim; Jae-Il Kim; Richard I Carp; Yong-Sun Kim
Journal:  J Hum Genet       Date:  2005-06-03       Impact factor: 3.172

Review 7.  The prion gene complex encoding PrP(C) and Doppel: insights from mutational analysis.

Authors:  P Mastrangelo; D Westaway
Journal:  Gene       Date:  2001-09-05       Impact factor: 3.688

8.  Molecular genetics of human prion diseases in Germany.

Authors:  O Windl; A Giese; W Schulz-Schaeffer; I Zerr; K Skworc; S Arendt; C Oberdieck; M Bodemer; S Poser; H A Kretzschmar
Journal:  Hum Genet       Date:  1999-09       Impact factor: 4.132

9.  Polymorphisms within the prion-like protein gene (Prnd) and their implications in human prion diseases, Alzheimer's disease and other neurological disorders.

Authors:  B Schröder; B Franz; P Hempfling; M Selbert; T Jürgens; H A Kretzschmar; M Bodemer; S Poser; I Zerr
Journal:  Hum Genet       Date:  2001-09       Impact factor: 4.132

10.  Sporadic--but not variant--Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1.

Authors:  S Mead; S P Mahal; J Beck; T Campbell; M Farrall; E Fisher; J Collinge
Journal:  Am J Hum Genet       Date:  2001-11-05       Impact factor: 11.025

View more
  21 in total

1.  Technologies in the Whole-Genome Age: MALDI-TOF-Based Genotyping.

Authors:  Nicolas Vogel; Katrin Schiebel; Andreas Humeny
Journal:  Transfus Med Hemother       Date:  2009-07-10       Impact factor: 3.747

2.  Association between the PRNP 1368 polymorphism and the occurrence of sporadic Creutzfeldt-Jakob disease.

Authors:  Jolanta Bratosiewicz-Wąsik; Joanna Smoleń-Dzirba; Annemieke J Rozemuller; Casper Jansen; Wim Spliet; Gerard H Jansen; Tomasz J Wąsik; Paweł P Liberski
Journal:  Prion       Date:  2012-08-16       Impact factor: 3.931

3.  A polymorphism in the YWHAH gene encoding 14-3-3 eta that is not associated with sporadic Creutzfeldt-Jakob disease (CJD).

Authors:  Jisuk Yun; Byung-Hoon Jeong; Hae-Jung Kim; Young-Jae Park; Yun-Jung Lee; Eun-Kyoung Choi; Richard I Carp; Yong-Sun Kim
Journal:  Mol Biol Rep       Date:  2011-07-08       Impact factor: 2.316

4.  A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes.

Authors:  Mercedes Muñoz-Nieto; Neus Ramonet; Juan Ignacio López-Gastón; Natividad Cuadrado-Corrales; Olga Calero; Marcos Díaz-Hurtado; José Ramón Ipiens; Santiago Ramón y Cajal; Jesús de Pedro-Cuesta; Miguel Calero
Journal:  J Neurol       Date:  2012-07-05       Impact factor: 4.849

5.  Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome.

Authors:  Paula Singmann; Jens Baumert; Christian Herder; Christa Meisinger; Christina Holzapfel; Norman Klopp; H-Erich Wichmann; Martin Klingenspor; Wolfgang Rathmann; Thomas Illig; Harald Grallert
Journal:  Obes Facts       Date:  2009-07-20       Impact factor: 3.942

6.  Genomic and post-genomic analyses of human prion diseases.

Authors:  Maurizio Pocchiari; Anna Poleggi; Serena Principe; Silvia Graziano; Franco Cardone
Journal:  Genome Med       Date:  2009-06-22       Impact factor: 11.117

7.  Genotype patterns and characteristics of PRNP in the Korean population.

Authors:  Sol Moe Lee; Young Ran Ju; Bo-Yeong Choi; Jae Wook Hyeon; Jun Sun Park; Chi Kyeong Kim; Su Yeon Kim
Journal:  Prion       Date:  2012-05-07       Impact factor: 3.931

8.  Genome wide association studies and prion disease.

Authors:  Ana Lukic; Simon Mead
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

9.  Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).

Authors:  Susanne Tan; André Scherag; Onno Eilard Janssen; Susanne Hahn; Harald Lahner; Tiina Dietz; Susann Scherag; Harald Grallert; Carla Ivane Ganz Vogel; Rainer Kimmig; Thomas Illig; Klaus Mann; Johannes Hebebrand; Anke Hinney
Journal:  BMC Med Genet       Date:  2010-01-21       Impact factor: 2.103

10.  Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.

Authors:  Simon Mead; Mark Poulter; James Uphill; John Beck; Jerome Whitfield; Thomas E F Webb; Tracy Campbell; Gary Adamson; Pelagia Deriziotis; Sarah J Tabrizi; Holger Hummerich; Claudio Verzilli; Michael P Alpers; John C Whittaker; John Collinge
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.